CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization

Open access
Chang, M C, Uang, B J, Tsai, C Y, Wu, H L, Lin, B R, Lee, C S, Chen, Y J, Chang, C H, Tsai, Y L, Kao, C J, Jeng, J H · 2007 · British Journal of Pharmacology

Abstract

Background and purpose: Platelet hyperactivity is important in the pathogenesis of cardiovascular diseases. Betel leaf (PBL) is consumed by 200‐600 million betel quid chewers in the world. Hydroxychavicol (HC), a betel leaf component, was tested for its antiplatelet effect. Experimental approach: We tested the effect of HC on platelet aggregation, thromboxane B 2 (TXB 2) and reactive oxygen species (ROS) production, cyclooxygenase (COX) activity, ex vivo platelet aggregation and mouse bleeding time and platelet plug formation in vivo. The pharmacokinetics of HC in rats was also assessed. Key results: HC inhibited arachidonic acid (AA) and collagen‐induced platelet aggregation and TXB 2 production. HC inhibited the thrombin‐induced TXB 2 production, but not platelet aggregation. SQ29548, suppressed collagen‐ and thrombin‐induced TXB 2 production, but not thrombin‐induced platelet aggregation. HC also suppressed COX‐1/COX‐2 enzyme activity and the AA‐induced ROS production and Ca 2+ mobilization. HC further inhibited the ex vivo platelet aggregation of platelet‐rich plasma (>100 nmole/mouse) and prolonged platelet plug formation (>300 nmole/mouse) in mesenteric microvessels, but showed little effect on bleeding time in mouse tail. Moreover, pharmacokinetics analysis found that more than 99% of HC was metabolized within 3 min of administration in Sprague‐Dawley rats in vivo. Conclusions and implications: HC is a potent COX‐1/COX‐2 inhibitor, ROS scavenger and inhibits platelet calcium signaling, TXB 2 production and aggregation. HC could be a potential therapeutic agent for prevention and treatment of atherosclerosis and other cardiovascular diseases through its anti‐inflammatory and antiplatelet effects, without effects on haemostatic functions. British Journal of Pharmacology (2007) 152, 73–82; doi:10.1038/sj.bjp.0707367

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0707367

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 57 references

Research works printed but not linked: 4

  1. Gierse JK, 1999, Kinetic basis for selective inhibition of cyclooxygenases, Biochem J, 339, 607, 10.1042/bj3390607 · doi:10.1042/bj3390607 · Paper page
  2. Huang LS, 1993, Phenolic compounds of piper betle flower as flavoring and neuronal activity modulating agents, Phenolic Compounds in Food and their Effects on Health I: Analysis, Occurrence and Chemistry
  3. IARC, 2004, IARC Monographs
  4. TsaiCC(2003).The association between areca/betel quid chewing cigarette smoking alcohol drinking and asthma heart disease and peptic ulcer in Taiwan. Master thesis Kaohsiung Medical University.

Cited by

See all 58

Metadata

Authors
Chang, M. C., Uang, B. J., Tsai, C. Y., Wu, H. L., Lin, B. R., Lee, C. S., Chen, Y. J., Chang, C. H., Tsai, Y. L., Kao, C. J., & Jeng, J. H.
Affiliations
  • National Tsing Hua University (TW)
  • Development Center for Biotechnology (TW)
  • National Taiwan University Hospital (TW)
  • National Taiwan University (TW)
Corresponding author
Jeng, J H
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2007-09
Volume
152
Issue
1
Pages
73-82
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1980926937
Cited by
58
References
57
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 3 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 8 · 2013: 2 · 2012: 4
FWCI
1.49
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science Council
  • Chang Gung Medical Foundation
Topics
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords
hydroxychavicol, betel leaf, antiplatelet activity, platelet aggregation, cyclooxygenase inhibition, thromboxane B2, reactive oxygen species, calcium mobilization, arachidonic acid, collagen-induced aggregation, thrombin-induced aggregation, pharmacokinetics, atherosclerosis, cardiovascular disease, SQ29548
MeSH terms
Animals, Bleeding Time, Blood Platelets, Collagen, Dose-Response Relationship, Drug, Eugenol, Male, Mice, Inbred ICR, Platelet Aggregation, Platelet Aggregation Inhibitors, Rabbits, Thrombin, Thromboxane B2, Arachidonic Acid, Cyclooxygenase Inhibitors, Rats, Sprague-Dawley, Reactive Oxygen Species, Plant Leaves, Calcium Signaling, Piper betle, Mice, Rats, Cyclooxygenase 1, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. https://app.cochat.ai/papers/10.1038/sj.bjp.0707367
The paper
Chang, M. C., Uang, B. J., Tsai, C. Y., Wu, H. L., Lin, B. R., Lee, C. S., Chen, Y. J., Chang, C. H., Tsai, Y. L., Kao, C. J., & Jeng, J. H. (2007). Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707367

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.